Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 (DIGEST)

This study has been terminated.
(Insufficient efficacy in planned interim futility analysis)
Sponsor:
Information provided by (Responsible Party):
Tranzyme, Inc.
ClinicalTrials.gov Identifier:
NCT01664637
First received: August 10, 2012
Last updated: December 18, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
No publications provided by Tranzyme, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):